Stock listing

SVRA Stock Price, News, Filings & Events — Savara, Inc.

Selected listing: SVRA · BOATS · USD · US

This page tracks Savara, Inc.'s SVRA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SVRA:BOATS. SVRA:BOATS is the stock-level entry point for investors researching Savara, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Savara, Inc. is a public company traded under the ticker SVRA in the American market. With a market capitalization of approximately $1.13 billion, Savara focuses on developing innovative treatments for patients with rare respiratory diseases. The company is committed to advancing its pipeline of therapies to improve patient outcomes.

SVRA:BOATSUSDUSUpdated September 4, 2026
Savara, Inc. logo
Ticker
SVRA:BOATS
Asset type
Stock
Market cap
$1.10B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Savara, Inc. SVRA:BOATS stock context

This page tracks Savara, Inc.'s SVRA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SVRA:BOATS. SVRA:BOATS is the stock-level entry point for investors researching Savara, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Savara, Inc. is a public company traded under the ticker SVRA in the American market. With a market capitalization of approximately $1.13 billion, Savara focuses on developing innovative treatments for patients with rare respiratory diseases. The company is committed to advancing its pipeline of therapies to improve patient outcomes.

Latest news from Savara, Inc.

All Savara, Inc. news →

Research Savara, Inc.

Alternate listings